From the Literature

Published: Sep 2001

Farrant B, Battin M, Roberts A

Outcome of infants receiving in-utero transfusions for haemolytic disease.
N Z Med J 2001;114(1139):400-403.

#

NATA REVIEW:
Retrospective analysis of infants receiving in-utero transfusion showing good outcome. No...
REVIEW by:

Published: Aug 2001

Shapira R, Zemel R, Gerecht S, et al.

Transfusion-transmitted virus in liver-transplanted children.
Transplant Proc 2001;33(6):2957-2958.

#

NATA REVIEW:
The article is also showing, what is already known, that TTV is transmitted by blood and transplants...
REVIEW by:
V. Kretschmer.

Published: Aug 2001

Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U

Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Haemophilia 2001;7(5):517-522.

#

NATA REVIEW:
This is a case report of a child with severe hemophilia B and high titer factor IX inhibitor...
REVIEW by:
M. Aldouri

Published: Aug 2001

Sakai H, Horinouchi H, Tomiyama K, et al.

Hemoglobin-vesicles as oxygen carriers - Influence on phagocytic activity and histopathological changes in reticuloendothelial system.
Am J Pathol 2001;159(3):1079-1088.

#

NATA REVIEW:
A good basic science article demonstrating that a single dose of hemoglobin encapsulated in...
REVIEW by:
J.-F. Hardy

Published: Aug 2001

Delle Chiaie L, Buck G, Grab D, Terinde R

Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection.
Ultrasound Obstet Gynecol 2001;18(3):232-236.

#

NATA REVIEW:
Measurement of middle artery peak systolic velocity by two-dimensional and Doppler ultrasound...
REVIEW by:
Kretschmer V.

Published: Aug 2001

van Kamp IL, Klumper FJC, Bakkum RS, et al.

The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
Am J Obstet Gynecol 2001;185(3):668-673.

#

NATA REVIEW:
This retrospective study shows that the severity of immune fetal hydrops and the response...
REVIEW by:
Kretschmer V.

Published: Aug 2001

Kheirabadi BS, Pearson R, Rudnicka K, et al.

Development of an animal model for assessment of the hemostatic efficacy of fibrin sealant in vascular surgery.
J Surg Res 2001;100(1):84-92.

#

NATA REVIEW:
Having a sound and reproducible animal model to test the value of an existing therapy beyond...
REVIEW by:
R. K. Spence

Published: Aug 2001

Martinowitz U, Kenet G, Segal E, et al.

Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
J Trauma 2001;51(3):431-438.

#

NATA REVIEW:
This is a relatively new area for using rFVIIa, which is to treat uncontrolled haemorrhage...
REVIEW by:
M. Aldouri

Published: Aug 2001

Vichinsky EP, Luban NLC, Wright E, et al.

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
Transfusion 2001;41(9):1086-1092.

#

NATA REVIEW:
For a transfusionist from West/North Europe, the results are predictable and the conclusion...
REVIEW by:
V. Kretschmer.

Published: Aug 2001

Chuansumrit A, Sri-Udomporn N, Srimuninnimit V, Juntarukha R

A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
Haemophilia 2001;7(5):532-534.

#

NATA REVIEW:
A single dose of rFVIIa (150-180 μg/kg) was used to treat five muscle/joint bleeds and...
REVIEW by:
M. Aldouri

Pages